Global Hybridoma Service Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11246450

Publication Date:

November 13, 2024

Pages:

123

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Hybridoma Services is a professional service designed to produce monoclonal antibodies through hybridoma technology. This service includes the entire process from immunizing mice or other hosts, cell fusion, screening and cloning selection to antibody production and purification. Hybridoma technology produces hybridoma cell lines that can proliferate indefinitely and stably express specific antibodies by fusing B cells with myeloma cells, and is widely used in scientific research, diagnosis and treatment.
The global Hybridoma Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (publisher)' newest research report, the 鈥淗ybridoma Service Industry Forecast鈥� looks at past sales and reviews total world Hybridoma Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Hybridoma Service sales for 2023 through 2029. With Hybridoma Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hybridoma Service industry.
This Insight Report provides a comprehensive analysis of the global Hybridoma Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hybridoma Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Hybridoma Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hybridoma Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hybridoma Service.
United States market for Hybridoma Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Hybridoma Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Hybridoma Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Hybridoma Service players cover Biocompare, Creative Biolabs, ProteoGenix, Genscript, Curia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Hybridoma Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Hybridoma Cell Culture Service
Hybridoma Antibody Production Service
Hybridoma Sequencing Service
Others
Segmentation by Application:
Drug Development
Diagnostic Reagent Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Hybridoma Cell Culture Service
Hybridoma Antibody Production Service
Hybridoma Sequencing Service
Others
Segmentation by Application:
Drug Development
Diagnostic Reagent Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biocompare
Creative Biolabs
ProteoGenix
Genscript
Curia
Sino Biological
BIOZOL
ProMab
Cell Culture Company
BioGenes GmbH
InVivo
Versiti
Eurogentec
Antibodies Inc
Penn Genetics
BIOTEM

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hybridoma Service Market Size 2019-2030
2.1.2 Hybridoma Service Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Hybridoma Service by Country/Region, 2019, 2023 & 2030
2.2 Hybridoma Service Segment by Type
2.2.1 Hybridoma Cell Culture Service
2.2.2 Hybridoma Antibody Production Service
2.2.3 Hybridoma Sequencing Service
2.2.4 Others
2.3 Hybridoma Service Market Size by Type
2.3.1 Hybridoma Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Hybridoma Service Market Size Market Share by Type (2019-2024)
2.4 Hybridoma Service Segment by Application
2.4.1 Drug Development
2.4.2 Diagnostic Reagent Development
2.4.3 Others
2.5 Hybridoma Service Market Size by Application
2.5.1 Hybridoma Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Hybridoma Service Market Size Market Share by Application (2019-2024)
3 Hybridoma Service Market Size by Player
3.1 Hybridoma Service Market Size Market Share by Player
3.1.1 Global Hybridoma Service Revenue by Player (2019-2024)
3.1.2 Global Hybridoma Service Revenue Market Share by Player (2019-2024)
3.2 Global Hybridoma Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Hybridoma Service by Region
4.1 Hybridoma Service Market Size by Region (2019-2024)
4.2 Global Hybridoma Service Annual Revenue by Country/Region (2019-2024)
4.3 Americas Hybridoma Service Market Size Growth (2019-2024)
4.4 APAC Hybridoma Service Market Size Growth (2019-2024)
4.5 Europe Hybridoma Service Market Size Growth (2019-2024)
4.6 Middle East & Africa Hybridoma Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas Hybridoma Service Market Size by Country (2019-2024)
5.2 Americas Hybridoma Service Market Size by Type (2019-2024)
5.3 Americas Hybridoma Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hybridoma Service Market Size by Region (2019-2024)
6.2 APAC Hybridoma Service Market Size by Type (2019-2024)
6.3 APAC Hybridoma Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hybridoma Service Market Size by Country (2019-2024)
7.2 Europe Hybridoma Service Market Size by Type (2019-2024)
7.3 Europe Hybridoma Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hybridoma Service by Region (2019-2024)
8.2 Middle East & Africa Hybridoma Service Market Size by Type (2019-2024)
8.3 Middle East & Africa Hybridoma Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Hybridoma Service Market Forecast
10.1 Global Hybridoma Service Forecast by Region (2025-2030)
10.1.1 Global Hybridoma Service Forecast by Region (2025-2030)
10.1.2 Americas Hybridoma Service Forecast
10.1.3 APAC Hybridoma Service Forecast
10.1.4 Europe Hybridoma Service Forecast
10.1.5 Middle East & Africa Hybridoma Service Forecast
10.2 Americas Hybridoma Service Forecast by Country (2025-2030)
10.2.1 United States Market Hybridoma Service Forecast
10.2.2 Canada Market Hybridoma Service Forecast
10.2.3 Mexico Market Hybridoma Service Forecast
10.2.4 Brazil Market Hybridoma Service Forecast
10.3 APAC Hybridoma Service Forecast by Region (2025-2030)
10.3.1 China Hybridoma Service Market Forecast
10.3.2 Japan Market Hybridoma Service Forecast
10.3.3 Korea Market Hybridoma Service Forecast
10.3.4 Southeast Asia Market Hybridoma Service Forecast
10.3.5 India Market Hybridoma Service Forecast
10.3.6 Australia Market Hybridoma Service Forecast
10.4 Europe Hybridoma Service Forecast by Country (2025-2030)
10.4.1 Germany Market Hybridoma Service Forecast
10.4.2 France Market Hybridoma Service Forecast
10.4.3 UK Market Hybridoma Service Forecast
10.4.4 Italy Market Hybridoma Service Forecast
10.4.5 Russia Market Hybridoma Service Forecast
10.5 Middle East & Africa Hybridoma Service Forecast by Region (2025-2030)
10.5.1 Egypt Market Hybridoma Service Forecast
10.5.2 South Africa Market Hybridoma Service Forecast
10.5.3 Israel Market Hybridoma Service Forecast
10.5.4 Turkey Market Hybridoma Service Forecast
10.6 Global Hybridoma Service Forecast by Type (2025-2030)
10.7 Global Hybridoma Service Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Hybridoma Service Forecast
11 Key Players Analysis
11.1 Biocompare
11.1.1 Biocompare Company Information
11.1.2 Biocompare Hybridoma Service Product Offered
11.1.3 Biocompare Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biocompare Main Business Overview
11.1.5 Biocompare Latest Developments
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Information
11.2.2 Creative Biolabs Hybridoma Service Product Offered
11.2.3 Creative Biolabs Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Creative Biolabs Main Business Overview
11.2.5 Creative Biolabs Latest Developments
11.3 ProteoGenix
11.3.1 ProteoGenix Company Information
11.3.2 ProteoGenix Hybridoma Service Product Offered
11.3.3 ProteoGenix Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 ProteoGenix Main Business Overview
11.3.5 ProteoGenix Latest Developments
11.4 Genscript
11.4.1 Genscript Company Information
11.4.2 Genscript Hybridoma Service Product Offered
11.4.3 Genscript Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Genscript Main Business Overview
11.4.5 Genscript Latest Developments
11.5 Curia
11.5.1 Curia Company Information
11.5.2 Curia Hybridoma Service Product Offered
11.5.3 Curia Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Curia Main Business Overview
11.5.5 Curia Latest Developments
11.6 Sino Biological
11.6.1 Sino Biological Company Information
11.6.2 Sino Biological Hybridoma Service Product Offered
11.6.3 Sino Biological Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sino Biological Main Business Overview
11.6.5 Sino Biological Latest Developments
11.7 BIOZOL
11.7.1 BIOZOL Company Information
11.7.2 BIOZOL Hybridoma Service Product Offered
11.7.3 BIOZOL Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 BIOZOL Main Business Overview
11.7.5 BIOZOL Latest Developments
11.8 ProMab
11.8.1 ProMab Company Information
11.8.2 ProMab Hybridoma Service Product Offered
11.8.3 ProMab Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ProMab Main Business Overview
11.8.5 ProMab Latest Developments
11.9 Cell Culture Company
11.9.1 Cell Culture Company Company Information
11.9.2 Cell Culture Company Hybridoma Service Product Offered
11.9.3 Cell Culture Company Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cell Culture Company Main Business Overview
11.9.5 Cell Culture Company Latest Developments
11.10 BioGenes GmbH
11.10.1 BioGenes GmbH Company Information
11.10.2 BioGenes GmbH Hybridoma Service Product Offered
11.10.3 BioGenes GmbH Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BioGenes GmbH Main Business Overview
11.10.5 BioGenes GmbH Latest Developments
11.11 InVivo
11.11.1 InVivo Company Information
11.11.2 InVivo Hybridoma Service Product Offered
11.11.3 InVivo Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 InVivo Main Business Overview
11.11.5 InVivo Latest Developments
11.12 Versiti
11.12.1 Versiti Company Information
11.12.2 Versiti Hybridoma Service Product Offered
11.12.3 Versiti Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Versiti Main Business Overview
11.12.5 Versiti Latest Developments
11.13 Eurogentec
11.13.1 Eurogentec Company Information
11.13.2 Eurogentec Hybridoma Service Product Offered
11.13.3 Eurogentec Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Eurogentec Main Business Overview
11.13.5 Eurogentec Latest Developments
11.14 Antibodies Inc
11.14.1 Antibodies Inc Company Information
11.14.2 Antibodies Inc Hybridoma Service Product Offered
11.14.3 Antibodies Inc Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Antibodies Inc Main Business Overview
11.14.5 Antibodies Inc Latest Developments
11.15 Penn Genetics
11.15.1 Penn Genetics Company Information
11.15.2 Penn Genetics Hybridoma Service Product Offered
11.15.3 Penn Genetics Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Penn Genetics Main Business Overview
11.15.5 Penn Genetics Latest Developments
11.16 BIOTEM
11.16.1 BIOTEM Company Information
11.16.2 BIOTEM Hybridoma Service Product Offered
11.16.3 BIOTEM Hybridoma Service Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BIOTEM Main Business Overview
11.16.5 BIOTEM Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂